ENvue Medical Inc. (NASDAQ:FEED) — Market Cap & Net Worth
Market Cap & Net Worth: ENvue Medical Inc. (FEED)
ENvue Medical Inc. (NASDAQ:FEED) has a market capitalization of $3.63 Million ($3.63 Million) as of August 24, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29219 globally and #5951 in its home market, demonstrating a 2.62% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ENvue Medical Inc.'s stock price $0.39 by its total outstanding shares 9296667 (9.30 Million). See FEED equity to assets ratio to understand what proportion of total assets are financed by equity.
ENvue Medical Inc. Market Cap History: 2026 to 2026
ENvue Medical Inc.'s market capitalization history from 2026 to 2026. Data shows growth from $3.63 Million to $3.63 Million (0.00% CAGR). Also see FEED total assets for a full breakdown of the balance sheet.
ENvue Medical Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ENvue Medical Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check FEED live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of FEED by Market Capitalization
Companies near ENvue Medical Inc. in the global market cap rankings as of August 24, 2026. Also see FEED cash generation efficiency for how efficiently the company converts equity into cash flow.
Key companies related to ENvue Medical Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #105 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #195 globally with a market cap of $126.37 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #232 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #249 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #105 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $116.64 |
| #195 | Stryker Corporation | NYSE:SYK | $126.37 Billion | $329.45 |
| #232 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.35 |
| #249 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
ENvue Medical Inc. Historical Marketcap From 2026 to 2026
Between 2026 and today, ENvue Medical Inc.'s market cap moved from $3.63 Million to $ 3.63 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.63 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 24th, 2026 the market cap of ENvue Medical Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.63 Million USD |
| MoneyControl | $3.63 Million USD |
| MarketWatch | $3.63 Million USD |
| marketcap.company | $3.63 Million USD |
| Reuters | $3.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ENvue Medical Inc.
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, incre… Read more